8 Sano dhoofiye Coronavirus ah oo tijaabiyey Aadanaha - 2019-nCOV IgGIgM Qalabka Tijaabada Degdega ah (hal adeeg) - Realy
8 Sano dhoofiye Coronavirus ah oo tijaabiyey Aadanaha - 2019-nCOV IgGIgM Qalabka Tijaabada Degdega ah (hal adeeg) - RealyDetail:
Dareenka iyo Gaarka: Aaladda 2019-nCOV/COVID-19 IgG/IgM Qalabka Tijaabada Degdegga ah ayaa la barbardhigay RT-Tijaabada PCR ee hormuudka ka ah iyada oo la adeegsanayo muunado caafimaad. Natiijooyinku waxay muujinayaan in 2019-nCoV/COVID-19 IgG/IgM Qalabka Tijaabada Degdegga ah uu leeyahay dareen sare iyo gaar ahaaneed.
Imtixaanka IgG:
| Habka | RT-PCR | Wadarta Natiijooyinka | ||
| 2019-nCOV IgG/IgM Qalabka Tijaabada Degdega ah | Natiijooyinka | Wanagsan | xun | |
| Wanagsan | 233 | 2 | 235 | |
| xun | 35 | 287 | 322 | |
| Wadarta Natiijooyinka | 268 | 289 | 557 | |
Dareenka Qaraabada:233/268=86.94%(95%CI*:82.35%-90.49%)
Gaar ahaan Qaraabada:287/289=99.31% (95%CI*:97.52%-99.92%)
Sax:520/557=93.36% (95%CI*: 90.96%-95.16%)
* Kalsoonida Dhexdeeda
Imtixaanka IgM
| Habka | RT-PCR | Wadarta Natiijooyinka | ||
| 2019-nCOV IgG/IgM Qalabka Tijaabada Degdega ah | Natiijooyinka | Wanagsan | xun | |
| Wanagsan | 223 | 7 | 230 | |
| xun | 45 | 282 | 327 | |
| Wadarta Natiijooyinka | 268 | 289 | 557 | |
Dareenka Qaraabada:223/268=83.21% (95%CI*:78.19%-87.48%)
Gaar ahaan Qaraabada:282/289=97.58% (95%CI*: 95.07%-99.02%)
Saxnimada: 505/557=90.66% (95%CI*: 87.94%-92.95%)
* Kalsoonida Dhexdeeda
The 2019-nCOV/COVID-19 IgG/IgM Qalabka Tijaabada Degdega ah waa immunoassay chromatographic degdeg ah oo loogu talagalay ogaanshaha tayada ee IgG&IgM antibody of Coronavirus Disease 2019 ee dhiiga bini'aadamka oo dhan, serum, ama balaasmaha sida gargaar lagu ogaanayo caabuqyada COVID-19.
Isticmaalka la damacsan yahay: 2019-nCOV/COVID-19 IgG/IgM Qalabka Tijaabada Degdegga ah waa immunoassay chromatographic degdeg ah oo loogu talagalay ogaanshaha tayada ee IgG&IgM antibody of Coronavirus Disease 2019 ee dhiiga bini'aadamka oo dhan, serum, ama balaasmaha si gargaar loogu helo ogaanshaha caabuqyada COVID-19.
KOOBAN: COVID-19 waa cudur faafa oo neef-mareenka oo degdeg ah. Dadku guud ahaan waa u nugul yihiin. Hadda, bukaannada uu ku dhacay cudurka 'coronavirus' cusub ayaa ah isha ugu weyn ee caabuqa; Dadka cudurka asymptomatic-ka ah sidoo kale waxay noqon karaan il faafa. Iyada oo ku saleysan baaritaanka cudurrada faafa ee hadda, muddada soo-baxa waa 1 ilaa 14 maalmood, badiyaa 3 ilaa 7 maalmood. Calaamadaha ugu waaweyn waxaa ka mid ah qandho, daal iyo qufac qalalan. Sanka oo ciriiri ah, diif, cune xanuun, myalgia iyo shuban ayaa laga helaa dhowr xaaladood.
Tilmaamaha Isticmaalka: Oggolow qalabka tijaabada, muunada, kaydinta, iyo/ama kontaroolada inay gaadhaan heerkulka qolka (15-30°C) kahor tijaabada. 1. Keen kiishka heerkulka qolka ka hor inta aanad furin. Ka saar aaladda tijaabada shandad xidhan oo isticmaal sida ugu dhakhsaha badan. 2. Dhig qalabka tijaabada dusha nadiif ah oo siman. ? Noocyada Serum ama Plasma: Isticmaalka pipette la tuuri karo oo ah 10μL, soo jiid muunada ilaa khadka Buuxinta, oo ku wareeji 10μL serum/plasma muunada si fiican ee aaladda tijaabada, ka dibna ku dar 2 dhibcood oo kayd ah oo bilow saacada. ? Dhiiga Dhan (Venipuncture/Fingerstick) Noocyada: Isticmaalka pipette la tuuri karo ee 10μL ah, oo ku wareeji 1 dhibcood oo dhiig ah (qiyaastii 20μL) muunada si fiican ee aaladda tijaabada,kadib ku dar 2 dhibcood oo bakhaar ah oo bilow saacada. Fiiro gaar ah: Muunadaha waxa kale oo lagu marsiin karaa micropipette. 3. Sug inta laynka midabka leh uu soo baxayo.Akhri natiijada 10 daqiiqo. Ha fasirin natiijada 15 daqiiqo ka dib.

Mabda'a: Qalabkani waxa uu isticmaalaa immunochromatography.Kaarka tijaabada waxa uu ka kooban yahay:1) kolloidal dahab ah-lagu calaamadeeyay recombinant novel coronavirus antigen iyo ilaalinta tayada ilaalinta caalamadaha dahabka;2) laba xariiq oo ogaanshaha (IgG iyo IgM khadadka) iyo hal tayada xakamaynta (C line) ee xuubka nitrocellulose. Khadka M waxa lagu dhaqaajiyaa iyada oo leh monoclonal anti - antibody IgM bini aadamka si loo ogaado cudurka cusub ee coronavirus IgM antibody; khadka IgG waxa lagu dhaqaajiyay reagent si loo ogaado cudurka cusub ee coronavirus IgG antibody; iyo khadka C waa mid aan dhaqdhaqaaq lahayn oo leh antibody-ka ilaalinta tayada. Marka qadar ku habboon muunadda tijaabada lagu daro daloolka muunadda ee kaadhka tijaabada, muunadda ayaa hore ugu sii socon doonta kaadhka tijaabada iyada oo la raacayo ficilka xididka Dhismaha difaaca jirka waxa qabsan doona ka hortagga - bini'aadamka IgM ka-hortagga xuubka si uu u sameeyo khad guduudan Haddii shaybaarku ka kooban yahay antibody IgG, antibody-gu wuxuu ku xidhmi doonaa dahabka kolloidalka ah ee ku suntan coronavirus antigen, iyo isku dhafka difaaca jirka waxaa qaban doona reagent immobilized on xuubka si uu u sameeyo guduud - guduudan IgG line, taasoo muujinaysa in novel coronavirus IgG antibody waa togan. Haddii baaritaanka IgG iyo IgM aysan midab lahayn, natiijo xun ayaa soo baxaysa. Kaarka tijaabada sidoo kale wuxuu ka kooban yahay xariiqda xakamaynta tayada C. Khadka xakamaynta tayada fuchsia C waa inuu soo muuqdaa iyada oo aan loo eegin haddii xariiqda tijaabada ahi u muuqato. Haddii xariiqda xakamaynta tayada C uusan soo bixin, natiijadu waa mid aan sax ahayn, muunaddana waxay u baahan tahay in mar kale lagu tijaabiyo kaadh kale oo tijaabo ah.
Sawirro tafatiran ee alaabta:








Hagaha Alaabta La Xiriira:
Waxaan rabnaa in aan aragno qaab-xumo tayo leh oo ku dhex jira abuurista oo aan siino taageerada ugu habboon ee iibsada gudaha iyo dibedda si kal iyo laab ah muddo 8 Sano ah dhoofiye Coronavirus ah oo tijaabinaya Aadanaha - 2019-nCOV IgGIgM Qalabka Tijaabada Degdega ah (hal adeeg) - Realy, Alaabta ayaa siin doonta adduunka oo dhan, sida: Croatia, Ethiopia, Japan Waxaan raadineynaa iskaashi ganacsi oo waqti dheer ah, waxaanan hubineynaa alaab-qeybiyeyaashayada inay hubaal ka faa'iideysan doonaan mustaqbalka dhow iyo mustaqbalka labadaba.









